Long-term results of liver transplantation in familial amyloidotic polyneuropathy type I

Transplantation

Volumn 64, Issue 4, 1997, Pages 646-649

  Parrilla, P ^a   Ramirez, P ^a   Andreu, L F ^a   Bueno, S F ^a   Robles, R ^a   Miras, M ^a   Acosta, F ^a   Viader Farre, D ^b   De Mingo, P ^a   Bermejo, J ^a   Garrido, S F J ^a   Munar Ques, M ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b Fap Study Group   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYLOID NEUROPATHY; ARTICLE; CLINICAL ARTICLE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TRANSPLANTATION; LONG TERM EXPOSURE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AMYLOID NEUROPATHIES; ELECTROMYOGRAPHY; FOLLOW-UP STUDIES; HUMANS; LIVER TRANSPLANTATION; MIDDLE AGED; SURVIVAL RATE;

EID: 0030883088     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199708270-00017     Document Type: Article

References (12)

1. Andrade C. A peculiar form of peripheral neuropathy: familial atypical generalized amyloidosis with special involvement of peripheral nerves. Brain 1952; 75: 408.
2. Ando Y, Ikegama S, Miyazaki A, et al. Role of variant prealbumin in the pathogenesis of familiar amyloidotic polyneuropathy: rate of normal and variant prealbumin in circulation. Arch Biochem Biophys 1989; 274: 87.
3. Holmgrem G, Steen L, Ekstedt J, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991; 40: 242.
4. Parrilla P, Lopez-Andreu FR, Ramirez P, et al. Familial amyloidotic polyneuropathy type I (Andrade's disease), a new indication for liver transplant. Transplantation 1994; 57: 473.
5. Skinner M, Lewis WD, Jones LA, et al. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med 1994; 120: 133.
6. Suhr OB, Holmgren G, Steen L, et al. Liver transplantation in familial amyloidotic polyneuropathy: follow-up of the first 20 Swedish patients. Transplantation 1995; 60(9): 933.
7. Costa PMP, Teixeira A, Regnault V, Saraiva MJM, Costa PP. A monoclonal antibody that recognizes several distinct amyloidogenic TTR variants. Arq Med 1990; 3 (suppl): 13.
8. Sales-Luis Ml, Alves MM, Carvalho M, et al. Familial amyloidotic polyneuropathy (Portuguese type): electroneurophysiological evaluation of FAP evolution. Symposium on Familial Amyloidotic Polyneurophaty. 6th European Congress of Clinical Neurophysiology. Porto, Portugal, September, 1992.
9. Wikstrom L, Holmgreg G, Steen L. Treatment of orthostatic hypotension in patients with familial amyloidotic polyneuropathy with l-threo-dops: an open pilot study. In: Abstracts of the 2nd International Symposium on Familial Amyloidotic Polyneuropathy and other transthyretin related disorders. Skelleftea, Sweden, 1992: 50.
10. Starlz TE, Iwatsuki S, Esquivel CO, et al. Refinements in the surgical technique of liver transplantation. Semin Liver Dis 1985; 5: 349.
11. Calne RY. Pretransplant assessment laparotomy m tumour cases, recipient operation in adults and in children and retransplantation. In: Calne SRY, ed. Liver transplantation. London: Grune and Stratton, 1987.
12. Ando Y, Tanaka Y, Ando E, et al. Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I. Lancet 1995; 345: 195.